DE3226320A1 - Plasminogenaktivator und verfahren zu seiner herstellung - Google Patents

Plasminogenaktivator und verfahren zu seiner herstellung

Info

Publication number
DE3226320A1
DE3226320A1 DE19823226320 DE3226320A DE3226320A1 DE 3226320 A1 DE3226320 A1 DE 3226320A1 DE 19823226320 DE19823226320 DE 19823226320 DE 3226320 A DE3226320 A DE 3226320A DE 3226320 A1 DE3226320 A1 DE 3226320A1
Authority
DE
Germany
Prior art keywords
medium
cells
plasminogen activator
serum
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823226320
Other languages
German (de)
English (en)
Other versions
DE3226320C2 (cg-RX-API-DMAC7.html
Inventor
Zvi Rehovot Bohak
Avinoam Petach Tikvah Kadouri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE3226320A1 publication Critical patent/DE3226320A1/de
Application granted granted Critical
Publication of DE3226320C2 publication Critical patent/DE3226320C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE19823226320 1981-07-15 1982-07-14 Plasminogenaktivator und verfahren zu seiner herstellung Granted DE3226320A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL63317A IL63317A (en) 1981-07-15 1981-07-15 Production of plasminogen activator

Publications (2)

Publication Number Publication Date
DE3226320A1 true DE3226320A1 (de) 1983-02-10
DE3226320C2 DE3226320C2 (cg-RX-API-DMAC7.html) 1989-08-17

Family

ID=11052764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823226320 Granted DE3226320A1 (de) 1981-07-15 1982-07-14 Plasminogenaktivator und verfahren zu seiner herstellung

Country Status (6)

Country Link
JP (1) JPS5865219A (cg-RX-API-DMAC7.html)
DE (1) DE3226320A1 (cg-RX-API-DMAC7.html)
FR (1) FR2510604B1 (cg-RX-API-DMAC7.html)
GB (1) GB2104081B (cg-RX-API-DMAC7.html)
IL (1) IL63317A (cg-RX-API-DMAC7.html)
IT (1) IT1195939B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60158115A (ja) * 1984-01-30 1985-08-19 Meiji Milk Prod Co Ltd プラズミノーゲンアクチベーターの製造法
JPS60259187A (ja) * 1984-04-19 1985-12-21 マイルス・ラボラトリ−ス・インコ−ポレ−テツド プラスミノーゲン活性化因子を増収する方法
DE3479814D1 (en) * 1984-06-05 1989-10-26 Asahi Chemical Ind Process for the preparation of a plasminogen activator
US4550080A (en) * 1984-06-05 1985-10-29 Asahi Kasei Kogyo Kabushiki Kaisha Process for the preparation of a plasminogen activator
WO1989009257A1 (en) * 1988-03-22 1989-10-05 Invitron Corporation METHOD TO ENHANCE tPA PRODUCTION
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
DE4128953A1 (de) * 1991-08-30 1993-03-04 Basf Ag Verfahren zur kultivierung von saeugerzellen im fliessbettreaktor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232124A (en) * 1979-04-23 1980-11-04 Mann George F Method of producing plasminogen activator
JPS55144887A (en) * 1979-04-26 1980-11-12 Asahi Chem Ind Co Ltd Preparation of physiologically active substance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Also Published As

Publication number Publication date
FR2510604A1 (fr) 1983-02-04
IL63317A0 (en) 1981-10-30
JPS5865219A (ja) 1983-04-18
IT1195939B (it) 1988-11-03
IL63317A (en) 1985-05-31
DE3226320C2 (cg-RX-API-DMAC7.html) 1989-08-17
GB2104081A (en) 1983-03-02
FR2510604B1 (fr) 1985-07-12
JPH0137115B2 (cg-RX-API-DMAC7.html) 1989-08-04
IT8222392A1 (it) 1984-01-14
GB2104081B (en) 1985-06-12
IT8222392A0 (it) 1982-07-14

Similar Documents

Publication Publication Date Title
DE3783643T2 (de) Anheftende biomaterialien fuer die adhaesion von zellen und geweben.
DE2651685C2 (de) Züchtung von Keratinozyten
EP0260610B1 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE69506781T2 (de) Zellkultursubstrate und Verfahren zu ihrer Anwendung
DE3033885C2 (cg-RX-API-DMAC7.html)
DE2636206C3 (de) Trägerfixierte Enzyme sowie ihre Herstellung und Anwendung
DE2940150A1 (de) Mikrotraeger-zellkultur
DE2726313B2 (de) Verfahren zur in-vitro-Biosynthese von Hormonen, insbesondere von Insulin
DE3027105A1 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors
DE2314076C3 (de) Verfahren zur Herstellung von karzinoembyonischem Antigen
DE2941310A1 (de) Verfahren zur herstellung eines stoffs mit bakteriostatischer aktivitaet
DE3226320C2 (cg-RX-API-DMAC7.html)
DE3149457A1 (de) Verfahren zur herstellung saurer protease und diese bildende mutanten von pilzen der gattung aspergillus
CH683526A5 (de) Zellinie für die Herstellung von Antikörper bildenden Hybridomen, Verfahren zur Herstellung einer menschlichen Zellinie und Antikörper produzierendes Hybridom.
DE2759579C2 (de) Zellkulturmikroträger
CH638470A5 (de) Verfahren zum abbau von cyanursaeure.
DE2828073C2 (de) Verfahren zum Kultivieren von Viren
DE3319714A1 (de) Verfahren zur interferonherstellung
EP0150796A2 (de) Zellkulturmikroträger, Verfahren zu seiner Herstellung und seine Verwendung zum Züchten von verankerungsabhängigen Zellen
DE68913602T2 (de) Gewebe-Immobilisierungs- und Zellkultursystem und Verfahren zum Anbringen biologisch wirksamer Teile an einem Substrat.
DE2552354A1 (de) Verfahren zur kaeltebehandlung von rohem fisch und fleisch
DE1767183C3 (de) Verfahren zur Herstellung von mikrobiellem Labferment
DE69322893T2 (de) Verfahren zur Herstellung von Epsilon-poly-L-Lysin
DE3239863A1 (de) Verfahren zur herstellung von subkultivierbaren lymphokin-bildenden human-t-zellenhybridomas
DE3851372T2 (de) Von menschlichen B-lymphoblastoiden Zellen abstammender Faktor zur Stimulierung der Antikörperproduktion und Verfahren zur Antikörperherstellung unter Verwendung dieses stimulierenden Faktors.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee